Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Embolism is a dreaded complication of infective endocarditis (IE). Currently, antimicrobial therapy is the only medical intervention proven to decrease the risk of embolism associated with IE. We hypothesized that, because platelet aggregation is operative in the pathogenesis of vegetation formation, embolism associated with IE should occur less frequently among patients who have received prior, continuous daily antiplatelet therapy for noninfectious reasons. METHODS: We studied a retrospective cohort of adult patients with a diagnosis of IE who presented to the Mayo Clinic (Rochester, MN) during 1980-1998. The cohort was divided into 2 groups on the basis of whether they had received continuous daily antiplatelet therapy for at least 6 months prior to the time of hospitalization for IE. Antiplatelet therapy included aspirin, dipyridamole, clopidogrel, ticlopidine, or any of combination of these agents. The primary end point was a symptomatic embolic event that occurred prior to or during hospitalization. Multivariable logistic regression was used to assess the impact of continuous daily antiplatelet therapy on risk of symptomatic emboli associated with IE. RESULTS: One hundred forty-seven (24.5%) of 600 patients experienced a symptomatic embolic event; the most common embolic manifestation was stroke (in 48.2% of patients). Embolic events occurred significantly less often among those who had received prior, continuous daily antiplatelet therapy (12.0% of patients who had received therapy vs. 27.8% patients who had not receive therapy; P<.001). After adjustment for several covariates known to influence both risk of embolism and propensity for antiplatelet use, the adjusted odds ratio for a symptomatic embolic event was 0.36 (95% confidence interval, 0.19-0.68; P=.002) for patients receiving continuous daily antiplatelet therapy. CONCLUSIONS: The risk of symptomatic emboli associated with IE was reduced in patients who received continuous daily antiplatelet therapy before onset of IE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrospective, observational studies 290-296 have examined the impact, if any, of long-term antiplatelet therapy before the onset of IE on infection-related outcomes.Findings from these investigations have been mixed in terms of IE-related outcomes.”
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationExperience from a multicentre stroke register: a preliminary report.
Hatano, S. (1976) · Europe PMC (PubMed Central) · Cited by 1,526
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Echocardiography predicts embolic events in infective endocarditis
Di Salvo, G., Habib, G., Pergola, V., Avierinos, J.-F., Philip, E., Casalta, J.-P., Vailloud, J.-M., Derumeaux, G., Gouvernet, J., Ambrosi, P., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01206-7 · Cited by 457
Effect of ibuprofen on cardioprotective effect of aspirin
MacDonald, T., & Wei, L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12509-3 · Cited by 419
Heiro, M., Nikoskelainen, J., Engblom, E., Kotilainen, E., Marttila, R., & Kotilainen, P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2781 · Cited by 415
Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh, I. M., Steckelberg, J. M., Murad, H. S., Anavekar, N. S., Ghomrawi, H. M. K., Mirzoyev, Z., Moustafa, S. E., Hoskin, T. L., Mandrekar, J. N., Wilson, W. R., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3022 · Cited by 366
Self-citationSanfilippo, A. J., Picard, M. H., Newell, J. B., Rosas, E., Davidoff, R., Thomas, J. D., & Weyman, A. E. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90535-h · Cited by 328
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
MICHELSON, A. D., CATTANEO, M., EIKELBOOM, J. W., GURBEL, P., KOTTKE‐MARCHANT, K., KUNICKI, T. J., PULCINELLI, F. M., CERLETTI, C., & RAO, A. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01351.x · Cited by 325
GARVEY, G. J., & NEU, H. C. (1978) · Medicine · doi:10.1097/00005792-197803000-00001 · Cited by 294
Kurth, T., Glynn, R. J., Walker, A. M., Chan, K. A., Buring, J. E., Hennekens, C. H., & Gaziano, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000087593.07533.9b · Cited by 254
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
Chan, K.-L., Dumesnil, J. G., Cujec, B., Sanfilippo, A. J., Jue, J., Turek, M. A., Robinson, T. I., & Moher, D. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00829-5 · Cited by 244
Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina
Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Di Gregorio, D., Bucciarelli, T., Davı̀, G., Cuccurullo, F., & Patrono, C. (2000) · Circulation · doi:10.1161/01.cir.102.9.1007 · Cited by 226
Influence of referral bias on the apparent clinical spectrum of infective endocarditis
Steckelberg, J. M., Rouse, M. S., Wilson, W. R., Melton, L. J., & Ilstrup, D. M. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90521-e · Cited by 206
Self-citationKupferwasser, L. I., Yeaman, M. R., Nast, C. C., Kupferwasser, D., Xiong, Y.-Q., Palma, M., Cheung, A. L., & Bayer, A. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16876 · Cited by 182
Kupferwasser, L. I., Yeaman, M. R., Shapiro, S. M., Nast, C. C., Sullam, P. M., Filler, S. G., & Bayer, A. S. (1999) · Circulation · doi:10.1161/01.cir.99.21.2791 · Cited by 169 · cited 4×
“In contrast to lower doses of aspirin, which diminished vegetation size and endocarditis severity, higher doses of aspirin had no such effects, possibly because of inhibition of prostacyclin synthesis [5].”
BackgroundResultInfluentialReduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate
Domenico, P., Schwartz, S., & Cunha, B. A. (1989) · Infection and Immunity · doi:10.1128/iai.57.12.3778-3782.1989 · Cited by 168
Narrative Review: Aspirin Resistance and Its Clinical Implications
Sanderson, S., Emery, J., Baglin, T., & Kinmonth, A.-L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00012 · Cited by 160
Kupferwasser, L. I., Yeaman, M. R., Nast, C. C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316876 · Cited by 152
Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases
Wu, A. H. B., & Tsongalis, G. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01553-3 · Cited by 133
Aspirin Resistance and Genetic Polymorphisms
Cambria-Kiely, J. A., & Gandhi, P. J. (2002) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1022066305399 · Cited by 118
Fabri, J., Issa, V. S., Pomerantzeff, P. M. A., Grinberg, M., Barretto, A. C. P., & Mansur, A. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.07.016 · Cited by 109
Cerebrovascular accidents in infective endocarditis: role of anticoagulation
DELAHAYE, J. P., PONCET, P., MALQUARTI, V., BEAUNE, J., GARÉ, J. P., & MANN, J. M. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059645 · Cited by 87
Polonio, R. E., Mermel, L. A., Paquette, G. E., & Sperry, J. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3262-3266.2001 · Cited by 86
Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study
Curtis, J. P., Wang, Y., Portnay, E. L., Masoudi, F. A., Havranek, E. P., & Krumholz, H. M. (2003) · BMJ · doi:10.1136/bmj.327.7427.1322 · Cited by 85
Farber, B. F., & Wolff, A. G. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.4.861 · Cited by 75
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis
Nicolau, D. P., Freeman, C. D., Nightingale, C. H., Quintiliani, R., Coe, C. J., Maderazo, E. G., & Cooper, B. W. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1593-1595.1993 · Cited by 73
Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis
Nicolau, D. P., Marangos, M. N., Nightingale, C. H., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1748 · Cited by 68
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis
TAHA, T. H., DURRANT, S. S., MAZEIKA, P. K., NIHOYANNOPOULOS, P., & OAKLEY, C. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00971.x · Cited by 60
Endocarditis in an Urban Hospital in the 1990s
Siddiq, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440200072008 · Cited by 57
Nicolau, D. P., Tessier, P. R., & Nightingale, C. H. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00092-2 · Cited by 52
Liesener, S. (2000) · Platelets · doi:10.1080/095371000403125 · Cited by 41
Weinberger, J. M. (2005) · Drugs · doi:10.2165/00003495-200565040-00003 · Cited by 36
Yusuf, S. W., Ali, S. S., Swafford, J., Durand, J., Bodey, G. P., Chemaly, R. F., Kontoyiannis, D. P., Tarrand, J. J., Rolston, K. V., Yeh, E. T. H., et al. (2006) · Medicine · doi:10.1097/01.md.0000208503.06288.7b · Cited by 36
Genetic and Acquired Determinants of Individual Variability of Response to Antiplatelet Drugs
Schafer, A. I. (2003) · Circulation · doi:10.1161/01.cir.0000088843.52678.8a · Cited by 36
Lien, E. A., SOLBERG, C. O., & Kalager, T. (1988) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548809032446 · Cited by 30
Nicolau, D. P., Tessier, P. R., Nightingale, C. H., & Quintiliani, R. (1998) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(97)00056-3 · Cited by 26
Population-Based Screening for Celiac Disease
Buchman, A. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.4.370 · Cited by 12
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Metadata
- Authors
- Anavekar, N. S., Tleyjeh, I. M., Anavekar, N. S., Mirzoyev, Z., Steckelberg, J. M., Haddad, C., Khandaker, M. H., Wilson, W. R., Chandrasekaran, K., & Baddour, L. M.
- Affiliations
- King Fahd Medical City (SA)
- Mayo Clinic (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 44
- Issue
- 9
- Pages
- 1180-1186
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2149023309
- Semantic Scholar
- eda90418fcdc68283dde09b5ba5c8a029226bcb1
- Cited by
- 138
- References
- 44
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 12 · 2019: 5 · 2018: 3 · 2017: 1 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 11 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- infective endocarditis, embolism, antiplatelet therapy, aspirin, clopidogrel, ticlopidine, dipyridamole, stroke, platelet aggregation, embolic complications
- MeSH terms
- Clopidogrel, Aged, Aspirin, Dipyridamole, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Embolism, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Retrospective Studies, Ticlopidine, Incidence, Prevalence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.